Discontinued — last reported Q4 '20
Woodward Business Sale Proceeds decreased by 35.7% to $2.03M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 125.0%, from $900.00K to $2.03M. Over 3 years (FY 2021 to FY 2025), Business Sale Proceeds shows an upward trend with a 587.6% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $55.00K | $13.00K | $1.00K | $4.00K | $0.00 | $6.00M | $30.00K | $169.00K | $278.00K | $11.00K | $300.00K | $900.00K | $1.44M | $43.46M | $3.15M | $2.03M |
| QoQ Change | — | -76.4% | -92.3% | +300.0% | -100.0% | — | -99.5% | +463.3% | +64.5% | -96.0% | >999% | +200.0% | +59.8% | >999% | -92.8% | -35.7% |
| YoY Change | — | — | — | — | -100.0% | >999% | >999% | >999% | — | -99.8% | +7.9% | >999% | — | — | +949.0% | +125.0% |